Skip to main content
Top
Published in: Cancer Causes & Control 9/2012

01-09-2012 | Original paper

Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys

Authors: Martin C. S. Wong, George K. John, Hoyee W. Hirai, Thomas Y. T. Lam, Arthur K. C. Luk, Jessica Y. L. Ching, Simon S. M. Ng, Francis K. L. Chan, Sian M. Griffiths, Joseph J. Y. Sung

Published in: Cancer Causes & Control | Issue 9/2012

Login to get access

Abstract

Purpose

Colorectal cancer (CRC) is one of the leading causes of cancer mortality worldwide. This study examined factors influencing the choice of participants between colonoscopy and fecal immunochemical test (FIT) in a screening program and the impact of an unbiased educational session on influencing this decision.

Methods

Data from 7,845 participants who underwent screening between May 2008 and April 2011 was analyzed. Binary logistic regression and multinomial regression were performed to calculate the odds of selection of colonoscopy instead of FIT and the impact of the educational session on final participant choice, respectively.

Results

Of the 7,845 participants, 4,796 (61 %) underwent FIT and 3,049 (39 %) underwent colonoscopy. A significant number of participants changed their initial choice after the educational session, with 27.1 % changing to FIT from colonoscopy and 8 % changing from FIT to colonoscopy. Age, educational level, occupation, income, family history of CRC, perception of risk of CRC, and perceptions regarding CRC screening were significantly different among the groups choosing FIT and colonoscopy. Family history of CRC and high self-perception of CRC risk resulted in higher odds of choosing colonoscopy, whereas older age, single marital status, and negative perception of CRC screening resulted in lower odds. Perceptions of overall health status, occupation, low income, younger age, and negative perceptions of CRC screening were associated with higher odds of change in screening choice.

Conclusions

Those at higher odds of changing CRC screening options should be supported with more detailed explanations by primary care physicians to secure a more informed and considered choice.
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer, Lyon, France
2.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69PubMedCrossRef
3.
go back to reference Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378PubMedCrossRef Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378PubMedCrossRef
4.
go back to reference Hong Kong Cancer Registry HA (2008) Hong Kong Cancer Registry. Fast stats for colorectal cancer, 2008 Hong Kong Cancer Registry HA (2008) Hong Kong Cancer Registry. Fast stats for colorectal cancer, 2008
5.
go back to reference Sarfaty M, Feng S (2006) Choice of screening modality in a colorectal cancer education and screening program for the uninsured. J Cancer Educ 21:43–49PubMedCrossRef Sarfaty M, Feng S (2006) Choice of screening modality in a colorectal cancer education and screening program for the uninsured. J Cancer Educ 21:43–49PubMedCrossRef
6.
go back to reference Wong MC, Tsoi KK, Ng SS, Lou VW, Choi SY, Ling KW, Chan FK, Griffiths SM, Sung JJ (2010) A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese. Aliment Pharmacol Ther 32:74–82PubMedCrossRef Wong MC, Tsoi KK, Ng SS, Lou VW, Choi SY, Ling KW, Chan FK, Griffiths SM, Sung JJ (2010) A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese. Aliment Pharmacol Ther 32:74–82PubMedCrossRef
7.
go back to reference Cancer Expert Working Group (2010) Recommendations on colorectal cancer screening. Cancer Expert Working Group on Cancer Prevention and Screening, Hong Kong 2010 Cancer Expert Working Group (2010) Recommendations on colorectal cancer screening. Cancer Expert Working Group on Cancer Prevention and Screening, Hong Kong 2010
8.
go back to reference Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS, Yeoh KG, Goh KL, Sollano J, Rerknimitr R, Matsuda T, Wu KC, Ng S, Leung SY, Makharia G, Chong VH, Ho KY, Brooks D, Lieberman DA, Chan FK, Asia Pacific Working Group on Colorectal Cancer (2008) Asia Pacific consensus recommendations for colorectal cancer screening. Gut 57:1166–1176 Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS, Yeoh KG, Goh KL, Sollano J, Rerknimitr R, Matsuda T, Wu KC, Ng S, Leung SY, Makharia G, Chong VH, Ho KY, Brooks D, Lieberman DA, Chan FK, Asia Pacific Working Group on Colorectal Cancer (2008) Asia Pacific consensus recommendations for colorectal cancer screening. Gut 57:1166–1176
9.
go back to reference National Health Services UK (2011) NHS bowel cancer screening programme website National Health Services UK (2011) NHS bowel cancer screening programme website
10.
go back to reference USPSTF (2008) Screening for colorectal cancer: summary of recommendations. Services AfHRaQUSDoHH USPSTF (2008) Screening for colorectal cancer: summary of recommendations. Services AfHRaQUSDoHH
11.
go back to reference Levin TR (2012) The importance of choosing colorectal cancer screening tests: comment on “Adherence to colorectal cancer screening”. Arch Intern Med 172:582–583PubMedCrossRef Levin TR (2012) The importance of choosing colorectal cancer screening tests: comment on “Adherence to colorectal cancer screening”. Arch Intern Med 172:582–583PubMedCrossRef
12.
go back to reference Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, Muñoz R, Lau C, Somsouk M, El-Nachef N, Hayward RA (2012). Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 172:ioi120005575-582 Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, Muñoz R, Lau C, Somsouk M, El-Nachef N, Hayward RA (2012). Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 172:ioi120005575-582
13.
go back to reference Sung JJ, Choi SY, Chan FK, Ching JY, Lau JT, Griffiths S (2008) Obstacles to colorectal cancer screening in Chinese: a study based on the health belief model. Am J Gastroenterol 103:974–981PubMedCrossRef Sung JJ, Choi SY, Chan FK, Ching JY, Lau JT, Griffiths S (2008) Obstacles to colorectal cancer screening in Chinese: a study based on the health belief model. Am J Gastroenterol 103:974–981PubMedCrossRef
14.
go back to reference DeBourcy A, Lichtenberger S, Felton S, Butterfield K, Ahnen D, Denberg T (2008) Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med 23:169–174PubMedCrossRef DeBourcy A, Lichtenberger S, Felton S, Butterfield K, Ahnen D, Denberg T (2008) Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med 23:169–174PubMedCrossRef
15.
go back to reference Schroy Iii P, Glick J, Robinson P, Heeren T (2007) Screening preferences of patients at familial risk of colorectal cancer. Dig Dis Sci 52:2788–2795PubMedCrossRef Schroy Iii P, Glick J, Robinson P, Heeren T (2007) Screening preferences of patients at familial risk of colorectal cancer. Dig Dis Sci 52:2788–2795PubMedCrossRef
16.
go back to reference Janz NK, Lakhani I, Vijan S, Hawley ST, Chung LK, Katz SJ (2007) Determinants of colorectal cancer screening use, attempts, and non-use. Prev Med 44:452–458PubMedCrossRef Janz NK, Lakhani I, Vijan S, Hawley ST, Chung LK, Katz SJ (2007) Determinants of colorectal cancer screening use, attempts, and non-use. Prev Med 44:452–458PubMedCrossRef
17.
go back to reference Teng EJ, Friedman LC, Green CE (2006) Determinants of colorectal cancer screening behavior among Chinese Americans. Psycho-Oncology 15:374–381PubMedCrossRef Teng EJ, Friedman LC, Green CE (2006) Determinants of colorectal cancer screening behavior among Chinese Americans. Psycho-Oncology 15:374–381PubMedCrossRef
18.
go back to reference Hart AR, Barone TL, Mayberry JF (1997) Increasing compliance with colorectal cancer screening: the development of effective health education. Health Educ Res 12:171–180PubMedCrossRef Hart AR, Barone TL, Mayberry JF (1997) Increasing compliance with colorectal cancer screening: the development of effective health education. Health Educ Res 12:171–180PubMedCrossRef
Metadata
Title
Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys
Authors
Martin C. S. Wong
George K. John
Hoyee W. Hirai
Thomas Y. T. Lam
Arthur K. C. Luk
Jessica Y. L. Ching
Simon S. M. Ng
Francis K. L. Chan
Sian M. Griffiths
Joseph J. Y. Sung
Publication date
01-09-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 9/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0031-x

Other articles of this Issue 9/2012

Cancer Causes & Control 9/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine